2Scholz J,Steinfath M,Schulz M. Clinical pharmacokinetics of alfentanil,fentanil and sulfentanil[J].Clinical Pharmacokinetics,1996.275-292.doi:10.2165/00003088-199631040-00004.
3Smith I,White PF,Nathanson M. Propofol:an update on its clinical uses[J].Anesthesiology,1994.105-143.doi:10.1097/00000542-199409001-00104.
二级参考文献9
1Ben-Shlomo I, Finger J, Bar-Av E, et al. Propofol and fentanyl act additively for induction of anaesthesia. Anaesthsia, 1993,48:111-113.
2Vuyk J, Lira T, Engbers FH, et al. Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. Anaesthesiology, 1993,78 : 1036-1045.
3Vree TB, Baars AM, de Grood PM. High performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine. J Chromatogr, 1987,417 : 458-464.
4Kirkpatrick T, Cockshott ID, Douglas EJ, et al. Pharmacokineties of propofol (Diprivan)in elderly patients.British J Anaesthsia, 1988,60 : 146-150.
5Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth, 1997,9(Suppl 6) :23-26.
6Murat I, Billard V, Vernois J, et al. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anaesthesiology, 1996,84 : 526-532.
7Schutthr J, Ihmsen H. Population pharmacokinetics of propofol., a multicenter study. Anaesthesiology, 2000,92 :727-738.
8Schnider TW, Minto CF, Sharer SL, et al. The influence of age on propofol pharmacodynamics. Anaesthesiology,1999,90 : 1502-1516.
